HANSIZHUANG Sets Sail in Indonesia Market

The 1st China anti-PD-1 monoclonal antibody successfully approved in Southeast Asia – The 1st overseas approval of HANSIZHUANG, highlighting another major milestone of Henlius’ global strategy after HANQUYOU – Along with KGbio and other partners to develop and launch HANSIZHUANG in over…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.